Jump to main content
博士論文

Sufficient immunogenicity and safety of 13-valent pneumococcal conjugate vaccine in patients with hematological malignancies who were outside recommended ages for routine vaccination

Icons representing 博士論文
The cover of this title could differ from library to library. Link to Help Page

Sufficient immunogenicity and safety of 13-valent pneumococcal conjugate vaccine in patients with hematological malignancies who were outside recommended ages for routine vaccination

Persistent ID (NDL)
info:ndljp/pid/12509586
Material type
博士論文
Author
TAKESHITA, Kenichi
Publisher
-
Publication date
2022-03-31
Material Format
Digital
Capacity, size, etc.
-
Name of awarding university/degree
千葉大学 = Chiba University,博士(医学)
View All

Notes on use at the National Diet Library

本資料は、掲載誌(URI)等のリンク先にある学位授与機関のWebサイトやCiNii DissertationsLeave the NDL website. から、本文を自由に閲覧できる場合があります。

Notes on use

Note (General):

type:text研究科: 千葉大学大学院医学薬学府(先端医学薬学専攻)学位記番号: 千大院医薬博甲第医1964号

Holdings of Libraries in Japan

This page shows libraries in Japan other than the National Diet Library that hold the material.

Please contact your local library for information on how to use materials or whether it is possible to request materials from the holding libraries.

other

  • Chiba University Repository for Access to Outcomes from Research

    Digital
    You can check the holdings of institutions and databases with which Institutional Repositories DataBase(IRDB)(Institutional Repository) is linked at the site of Institutional Repositories DataBase(IRDB)(Institutional Repository).

Bibliographic Record

You can check the details of this material, its authority (keywords that refer to materials on the same subject, author's name, etc.), etc.

Digital

Material Type
博士論文
Author/Editor
TAKESHITA, Kenichi
Author Heading
Publication Date
2022-03-31
Publication Date (W3CDTF)
2022-03-31
Alternative Title
13価結合型肺炎球菌ワクチンは定期接種対象外年齢の血液腫瘍疾患患者においても安全で十分な免疫原性がある
Degree grantor/type
千葉大学 = Chiba University
Date Granted
2022-03-31
Date Granted (W3CDTF)
2022-03-31